Right where you need us: Meeting the challenges of global biopharmaceutical research and development
As the biopharmaceutical industry evolves to meet the demands of a challenging global marketplace, companies of all sizes are exploring a new approach to strategic partnerships to help them increase efficiency, accelerate time to market, reduce costs, and expand their reach into new markets. Economic pressures are also driving pharmaceutical companies to find new ways to develop their products by accessing clinical resources and patient populations around the world.
Global pharmaceutical product development
PAREXEL has been providing strategic pharmaceutical research and development services for the biopharmaceutical and medical device industries for more than 25 years. Our unsurpassed global network of in-depth expertise, clinical resources, and technology makes us the partner of choice for your complete development needs across every phase of the product lifecycle… every therapeutic area… and every geographic region. Our broad range of services includes:
- Early stage development and proof-of-concept studies
- Complete Phase III clinical research capabilities, with innovative site and patient recruitment approaches
- Risk management and pharmacovigilance programs
- Global pharmaceutical regulations compliance, pricing, and marketing strategies
- Biosimilar product development
- Industry-leading eClinical and medical imaging technologies
With offices in 54 countries, PAREXEL also has the local knowledge and clinical expertise to support your pharmaceutical product development needs anywhere in the world. Our extensive global experience encompasses the rapidly emerging markets of Central and Eastern Europe, Latin America, India, and the Asia/Pacific region, as well as North America and Western Europe. We can provide access to diverse patient populations to speed recruitment… extensive investigator databases in every therapeutic category to accelerate trial start-ups… regulatory affairs expertise that helps you avoid costly delays… comprehensive pricing and reimbursement strategies… and an extensive early-phase clinical trial network to help you make earlier – and better – “go/no-go” decisions.
By working in partnership with PAREXEL’s proven clinical research expertise and resources, your company can maximize its product assets, reduce fixed costs, and gain a competitive edge at a time when even a small advantage can deliver large dividends in the marketplace. Whatever your development requirements, PAREXEL is right where you need us to help meet the challenges of today’s biopharmaceutical marketplace.